ÌÇÐÄvlog´«Ã½

Latin America Pharmaceutical Contract Manufacturing Organization Market Share

Statistics for the 2023 & 2024 Latin America Pharmaceutical Contract Manufacturing Organization market share, created by ÌÇÐÄvlog´«Ã½â„¢ Industry Reports. Latin America Pharmaceutical Contract Manufacturing Organization share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Latin America Pharmaceutical Contract Manufacturing Organization Industry

The Latin American pharmaceutical contract manufacturing organization market is fragmented. Vendors are expanding across regions and forming strategic and collaborative initiatives with companies to increase their market share and profitability. Some of the recent developments in the market are,

  • February 2024 - Novo Holdings, a Denmark-based company, announced it would buy the US-based contract drug manufacturing company Catalent. Catalent operates in Latin American countries, including Argentina and Brazil. The acquisition is likely to increase Novo Holdings' manufacturing capability and geographic presence globally.
  • December 2023 - Acino Pharmaceutical AG, a contract manufacturer in Europe, announced the acquisition of M8 Pharmaceuticals, a biopharmaceutical company in Mexico, to expand the company's pharmaceutical operations in Latin America.

Latin America Pharmaceutical Contract Manufacturing Organization Market Leaders

  1. Catalent Inc.

  2. Boehringer Ingelheim Group

  3. Pfizer CentreSource (Pfizer Inc)

  4. Thermo Fisher Scientific Inc. (Patheon Inc.)

  5. Acino International AG

*Disclaimer: Major Players sorted in no particular order

Latin America Pharmaceutical Contract Manufacturing Organization Market Concentration

Latin America Pharmaceutical Contract Manufacturing Organization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)